Analyst Ratings for Crescent Biopharma Inc (CBIO)
CBIO Rating Summary
CBIO Price Target Summary
- Highest: $36.00 (H.C. Wainwright)
- Lowest: $28.00 (Stifel)
- Average: $33.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$33.00 (+158.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
Rating Score: 7.9 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/6/2026 | H.C. Wainwright » Updated 10/19/2026 |
Mitchell S. Kapoor | Upgrade | Buy (Neutral) |
36.00 (N/A) |
13.94 (12.75) |
-8.54% | Details |
| 8/22/2026 | TD Cowen | Tyl | New Coverage | Buy (N/A) |
N/A (N/A) |
16.23 (12.75) |
-21.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
